This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (42)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Revascularization  • Cardiovascular System  • Surgery  • Surgical Interventions  • Cardiovascular/ Cardiothoracic Surgery  • Randomized Controlled Trial  • Cardiovascular Disease/ Myocardial Infarction  • Cardiovascular Intervention  • Alert me on articles by topic  Social Bookmarking   What's this?

A Randomized Controlled Trial

Albert Schömig, MD; Julinda Mehilli, MD; David Antoniucci, MD; Gjin Ndrepepa, MD; Christina Markwardt, MD; Francesco Di Pede, MD; Stephan G. Nekolla, PhD; Klaus Schlotterbeck, MD; Helmut Schühlen, MD; Jürgen Pache, MD; Melchior Seyfarth, MD; Stefan Martinoff, MD; Werner Benzer, MD; Claus Schmitt, MD; Josef Dirschinger, MD; Markus Schwaiger, MD; Adnan Kastrati, MD; for the Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators

JAMA. 2005;293:2865-2872.

Context  No specifically designed studies have addressed the role of primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction (STEMI) presenting more than 12 hours after symptom onset. Current guidelines do not recommend reperfusion treatment in these patients.

Objective  To assess whether an immediate invasive treatment strategy is associated with a reduction of infarct size in patients with acute STEMI, presenting between 12 and 48 hours after symptom onset, vs a conventional conservative strategy.

Design, Setting, and Patients  International, multicenter, open-label, randomized controlled trial conducted from May 23, 2001, to December 15, 2004, of 365 patients aged 18 to 80 years without persistent symptoms admitted with the diagnosis of acute STEMI between 12 and 48 hours after symptom onset.

Interventions  Random assignment to either an invasive strategy (n=182) based predominantly on coronary stenting with abciximab or a conventional conservative treatment strategy (n=183).

Main Outcome Measures  The primary end point was final left ventricular infarct size according to single-photon emission computed tomography study with technetium Tc 99m sestamibi performed between 5 and 10 days after randomization in 347 patients (95.1%). Secondary end points included composite of death, recurrent MI, or stroke at 30 days.

Results  The final left ventricular infarct size was significantly smaller in patients assigned to the invasive group (median, 8.0%; interquartile range [IQR], 2.0%-15.8%) vs those assigned to the conservative group (median, 13.0%; IQR, 3.0%-27.0%; P<.001). The mean difference in final left ventricular infarct size between the invasive and conservative groups was –6.8% (95% confidence interval [CI], –10.2% to –3.5%). The secondary end points of death, recurrent MI, or stroke at 30 days occurred in 8 patients in the invasive group (4.4%) and 12 patients in the conservative group (6.6%) (relative risk, 0.67; 95% CI, 0.27-1.62; P = .37).

Conclusion  An invasive strategy based on coronary stenting with adjunctive use of abciximab reduces infarct size in patients with acute STEMI without persistent symptoms presenting 12 to 48 hours after symptom onset.

Author Affiliations: Deutsches Herzzentrum (Drs Schömig, Mehilli, Ndrepepa, Markwardt, Schühlen, Pache, Martinoff, Schmitt, and Kastrati), 1 Medizinische Klinik rechts der Isar (Drs Schömig, Seyfarth, and Dirschinger), and Klinik und Poliklinik für Nuklearmedizin rechts der Isar (Drs Nekolla and Schwaiger), Technische Universität, Munich, Germany; Azienda Ospedaliera Careggi, Florence, Italy (Dr Antoniucci); Ospedale Umberto I, Mestre, Italy (Dr Di Pede); Klinikum Traunstein, Germany (Dr Schlotterbeck); and Landeskrankenhaus Feldkirch, Austria (Dr Benzer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Acute PCI for ST-Segment Elevation Myocardial Infarction: Is Later Better Than Never?
Raymond J. Gibbons and Cindy L. Grines
JAMA. 2005;293(23):2930-2932.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h
Busk et al.
Eur Heart J 2009;30:1322-1330.
ABSTRACT | FULL TEXT  

Year 2008 ESC ST-segment elevation myocardial infarction guidelines: implications for the interventional cardiologist--from evidence to recommendations and practice
Van de Werf
Eur Heart J Suppl 2009;11:C31-C37.
FULL TEXT  

Abciximab in Patients With Acute ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial
Mehilli et al.
Circulation 2009;119:1933-1940.
ABSTRACT | FULL TEXT  

Mechanical Reperfusion and Long-term Mortality in Patients With Acute Myocardial Infarction Presenting 12 to 48 Hours From Onset of Symptoms
Ndrepepa et al.
JAMA 2009;301:487-488.
FULL TEXT  

Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial
Menon et al.
Eur Heart J 2009;30:183-191.
ABSTRACT | FULL TEXT  

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:
Authors/Task Force Members et al.
Eur Heart J 2008;29:2909-2945.
FULL TEXT  

Is an Occluded Artery Better Than an Open One?
Antoniucci
J Am Coll Cardiol Intv 2008;1:521-523.
FULL TEXT  

Reply
Abbate et al.
J Am Coll Cardiol 2008;52:580-582.
FULL TEXT  

Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part I: Primary Percutaneous Coronary Intervention
Stone
Circulation 2008;118:538-551.
FULL TEXT  

Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions
Stone
Circulation 2008;118:552-566.
FULL TEXT  

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction
Ellis et al.
NEJM 2008;358:2205-2217.
ABSTRACT | FULL TEXT  

Survival and Cardiac Remodeling Benefits in Patients Undergoing Late Percutaneous Coronary Intervention of the Infarct-Related Artery: Evidence From a Meta-Analysis of Randomized Controlled Trials
Abbate et al.
J Am Coll Cardiol 2008;51:956-964.
ABSTRACT | FULL TEXT  

Effect of Reperfusion on Left Ventricular Regional Remodeling Strains After Myocardial Infarction
Sakamoto et al.
Ann. Thorac. Surg. 2007;84:1528-1536.
ABSTRACT | FULL TEXT  

Acute Myocardial Infarction With Hyperoxemic Therapy (AMIHOT): A Prospective, Randomized Trial of Intracoronary Hyperoxemic Reperfusion After Percutaneous Coronary Intervention
O'Neill et al.
J Am Coll Cardiol 2007;50:397-405.
ABSTRACT | FULL TEXT  

Evolution of Left Ventricular Ejection Fraction and its Relationship to Infarct Size After Acute Myocardial Infarction
Ndrepepa et al.
J Am Coll Cardiol 2007;50:149-156.
ABSTRACT | FULL TEXT  

Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology
Alexander et al.
Circulation 2007;115:2570-2589.
ABSTRACT | FULL TEXT  

Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction.
Ting et al.
ANN INTERN MED 2006;145:610-617.
ABSTRACT | FULL TEXT  

Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction
Schomig et al.
Eur Heart J 2006;27:1900-1907.
ABSTRACT | FULL TEXT  

The Year in Interventional Cardiology
Dixon et al.
J Am Coll Cardiol 2006;47:1689-1706.
FULL TEXT  

Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial Infarction: A Randomized Controlled Trial
Zohlnhofer et al.
JAMA 2006;295:1003-1010.
ABSTRACT | FULL TEXT  

Evidently ...
LEHMAN
Evid. Based Med. 2005;10:167-167.
FULL TEXT  

Other articles noted
Evid. Based Med. 2005;10:191-192.
FULL TEXT  

Mechanical Reperfusion More Than 12 Hours After Acute Myocardial Infarction
Kanna and Almadi
JAMA 2005;294:2031-2031.
FULL TEXT  

Mechanical Reperfusion More Than 12 Hours After Acute Myocardial Infarction
Rubin and Warner
JAMA 2005;294:2030-2031.
FULL TEXT  

Reperfusion Decreases Infarct Size in Late Presentation STEMI
JWatch Emergency Med. 2005;2005:1-1.
FULL TEXT  

JournalScan
Heart 2005;91:1246-1248.
FULL TEXT  

Does Late Reperfusion After STEMI Improve Outcomes?
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT  

Is Late Mechanical Reperfusion Helpful After MI?
JWatch General 2005;2005:3-3.
FULL TEXT  

Reperfusion in acute myocardial infarction
DTB 2005;43:49-53.
ABSTRACT | FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2005;330:1469-1470.
FULL TEXT  

Acute PCI for ST-Segment Elevation Myocardial Infarction: Is Later Better Than Never?
Gibbons and Grines
JAMA 2005;293:2930-2932.
FULL TEXT